Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Personality Traits in Patients with Hodgkin Lymphoma.
Roso-Bas F, Alonso-Llobregat MD, Bento L, Sanchez-Gonzalez B, Herraez I, Garcia-Dilla P, Vallespir C, Rado F, Rodriguez R, Garcia-Pallarols F, Aguirre I, Bargay J, Sampol A, Salar A, Gutierrez A. Roso-Bas F, et al. Among authors: salar a. J Clin Med. 2021 Apr 12;10(8):1631. doi: 10.3390/jcm10081631. J Clin Med. 2021. PMID: 33921383 Free PMC article.
Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma.
Gimeno E, Sánchez-González B, Alvarez-Larrán A, Pedro C, Abella E, Comín J, Saumell S, García-Pallarols F, Gómez M, Besses C, Salar A. Gimeno E, et al. Among authors: salar a. Leuk Res. 2011 Mar;35(3):358-62. doi: 10.1016/j.leukres.2010.07.024. Epub 2010 Aug 12. Leuk Res. 2011. PMID: 20708263
NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma.
Gimeno E, Gómez M, González JR, Comín J, Alvarez-Larrán A, Sánchez-González B, Molina L, Domingo-Domenech E, Garcia-Pallarols F, Pedro C, Abella E, Vilaplana C, de Sanjosé S, Besses C, Salar A. Gimeno E, et al. Among authors: salar a. Leuk Res. 2011 Jun;35(6):715-20. doi: 10.1016/j.leukres.2011.01.018. Epub 2011 Feb 17. Leuk Res. 2011. PMID: 21333352
Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
Sanchez-Gonzalez B, Peñalver FJ, Medina A, Guillén H, Calleja M, Gironella M, Arranz R, Sebastian E, de Oña R, Cánovas A, de la Fuente I, Grande C, Sancho JM, Perez R, Domingo E, Lopez-Lorenzo JL, Prieto E, Panizo C, Gorosquieta A, Perez I, Cervera JM, Marin M, Mencha C, Ramila E, Salar A. Sanchez-Gonzalez B, et al. Among authors: salar a. Leuk Res. 2012 Jun;36(6):709-14. doi: 10.1016/j.leukres.2011.10.024. Epub 2011 Dec 7. Leuk Res. 2012. PMID: 22154023
Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.
González-Barca E, Canales M, Cortés M, Vidal MJ, Salar A, Oriol A, Bargay J, Bello JL, Sánchez JJ, Tomás JF, Donato E, Ferrer S, Caballero D; GELTAMO (Grupo Español de Linfoma y Trasplante de Médula Ósea). González-Barca E, et al. Among authors: salar a. Nucl Med Commun. 2013 Oct;34(10):946-52. doi: 10.1097/MNM.0b013e328363c695. Nucl Med Commun. 2013. PMID: 23880897 Clinical Trial.
190 results